health research centres uk

• Research and Development

The NIHR HealthTech Research Centre

Technological innovations have the potential to revolutionise healthcare services for everyone. The NIHR HealthTech Research Centre in Sustainable Innovation (HRC) is a partnership between the Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter, designed to streamline the development pipeline from prototype to commercial product.

The HRC is one of 14 newly established research centres across England with the objective of driving innovation in health technology. Our purpose is to work with businesses to support the development of medical devices, diagnostics and digital technologies, accelerating the regulatory approvals process and smoothing the adoption pathway into the NHS and other healthcare institutions.

Innovation in action

More About us

Patients front and centre

We use patient and physician feedback to improve usability, effectiveness and adoption leading to better products and an evidence base that aims to speed up the regulatory approval process.

Our core themes

The work of the HRC focuses on four core themes, which include projects focused on:

• Diagnostics and biomarkers
• Data-led research, ai and digital innovation
• Rehabilitation and frailty
• Sustainable innovation

A track record of innovation

Exeter Hip Stem: This hip replacement project, pioneered by the Royal Devon and the University of Exeter has transformed the lives of more than 2M  patients worldwide.

Type 1 Diabetes Genetic Risk Score (T1D-GRS):   We developed a simple, inexpensive and robust genetic test  to predict and classify type 1 diabetes with 97% accuracy. 

Capture and Recycling of Waste Volatile Anaesthetic Agents: Sagetech Medical approached us to supervise and support the validation work required to  progress an innovation that would recycle anaesthetic gases

Areas of expertise

Clinical staff

We have access to some of the best clinicians in their fields with specialist interests across all areas  of medical research.

Patient and Public Involvement and Engagement (PPIE)

By adopting a patient-centred approach, we place patients at the heart of HealthTech Design and Development.

Healthcare technical solutions

We co-develop and evaluate data algorithms, AI, Apps and sensor technology (on  person and in environments) for use in clinical and community settings. 

Infrastructure & facilities

We have systems and partnerships in place to quickly evaluate new technologies including;  the NIHR Exeter Biomedical Research Centre , the NIHR Applied Research Collaboration South West Peninsula   (PenARC), the Clinical Research Network South West Peninsula , the NIHR Exeter Clinical Research Facility and the  VSIM and Gillings centre. 

Collaboration and partnerships

We work with local, national and international companies as well as regulatory  bodies, NHS health and care organisations, charities and development partners

Navigating the regulatory landscape

We use our combined expertise to support the journey through regulation,  reducing the time to target, collect and present evidence.

Work with us

If you are looking for access to the best health technology research infrastructure, clinical and academic expertise and a fast track route through the regulatory approvals process, then get in touch by emailing [email protected]

Get in contact

Welcome to the temporary page for the NIHR Health Tech Research Centre, South West Peninsula.

Get in touch by emailing [email protected]

Download a brochure

Helpful websites

Last updated: March 01, 2024

Our site uses cookies to help give you a better experience. By continuing to use it you consent to the use of cookies as set out in our privacy policy.

Study at Cambridge

About the university, research at cambridge.

• Events and open days
• Fees and finance
• Student blogs and videos
• Why Cambridge
• Qualifications directory
• How to apply
• Fees and funding
• Frequently asked questions
• International students
• Continuing education
• Executive and professional education
• Courses in education
• How the University and Colleges work
• Visiting the University
• Term dates and calendars
• Video and audio
• Find an expert
• Publications
• International Cambridge
• Public engagement
• Giving to Cambridge
• For current students
• For business
• Colleges & departments
• Libraries & facilities
• Museums & collections
• Email & phone search

Communicating Diet and Activity Research

Public Health Research Centres of Excellence: achievements and impacts

28th March 2019

By building capacity and capability in public health research, a report released on 28 March 2019 shows how the UK-wide network of Centres of Excellence that includes CEDAR, has helped fuel future public health and prevention research.

Since 2008, partners in the UK Clinical Research Collaboration (UKCRC) have invested £37 million in a network of six Public Health Research Centres of Excellence (UKCRC centres) to increase infrastructure, build academic capacity in public health research in the UK and provide a platform to engage with policy and practice.

The report shows how 10-years of collaborative work by these centres – based in Edinburgh, Belfast, Newcastle, Nottingham, Cambridge and Cardiff – has exceeded expectations of what was thought possible back in 2008.

The UKCRC centres have expanded the pool of early-career researchers and nurtured their talent while creating new opportunities to work across academia, policy and practice. Researchers have gone on to expand their networks and advance their careers, securing fellowships and lectureships, winning awards and promotion. The UKCRC centres have been a strong magnet for leveraging significant additional funding to increase the volume and quality of public health research.

The centres have helped change the way we think about how to align research with the needs of policymakers and practitioners. By pioneering innovative new ways of responding to public health needs and providing rapid response evaluations for policy and practice partners, their work is helping researchers and practitioners to improve public health at a local level.

At the national level, the impact has been wide-reaching, with evidence from centre research programmes influencing the government sugar tax, encouraging healthy transport policies, providing guidance on physical activity, promoting health in schools and playing a leading role in government policy on tobacco smoking and vaping.

Centre collaborations and academic-policy partnerships have changed the public health landscape, paving the way for ambitious new prevention initiatives, like the UK Prevention Research Partnership .  

Professor Chris Whitty , Chair of the UKCRC Board and Chief Scientific Adviser for the Department of Health and Social Care, said:

This report shows how this initiative has built research capacity in public health in the UK. Considered untried and risky in 2006, the hard work and collaborative spirit of many researchers, managers and students, has strengthened evidence-based public health policy and practice. “Without these sorts of achievements, it is hard to see how further ambitious investment like the UK Prevention Research Partnership would have been feasible. I am very grateful to all the Research Directors that drove this forward, and they should be justly proud of their contribution to the field.”

The report includes a number of examples of CEDAR’s work in capacity building, research excellence, and impact. Highlights include:

• novel legal perspectives on the contribution of international policy and trade law to obesogenic, unsustainable food systems.
• pioneering natural experimental studies of travel infrastructure changes and their influence on physical activity and health
• research showing  how the physical and fiscal environments affect our food choices
• engagement with civil servants across national government to help bring greater evidence into policymaking

This work continues, not only within CEDAR, but across the MRC Epidemiology Unit , and in new initiatives such as the Global Diet and Activity Research Group and Network (GDAR ).

Prof Nick Wareham , Director of CEDAR and the MRC Epidemiology Unit said:

There is much to celebrate thanks to the UKCRC initiative, and much to look forward to. “It has enabled CEDAR to build significant public health research capacity: PhD studentships and post-doctoral posts have blossomed into promising academic careers, and our alumni are pursuing successful roles in academia, government and the private sector. “The initiative has supported the development of sustainable research in physical activity, dietary public health and public health modelling. And it has enabled observational studies to mature into the development and testing of public health interventions. “A key goal for CEDAR has been to build lasting impact beyond research, and we are grateful for the many productive relationships we have been able to forge with practitioners and policymakers regionally, nationally and internationally. “The coming years present significant and complex challenges for population health in the UK and around the world, and we look forward to continuing to play our part in tackling them.”

You can read the full report here (pdf).

The UKCRC Centres of Excellence are:

• Centre of Excellence for Public Health Northern Ireland (CoENI), Queens University Belfast
• Centre for Exercise, Diet and Activity Research (CEDAR), MRC Epidemiology Unit at the University of Cambridge
• The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), Cardiff University
• The Centre for Translational Research in Public Health in Public Health (Fuse), Newcastle University
• The Scottish Collaboration for Public Health Research and Policy (SCPHRP), University of Edinburgh.
• The UK Centre for Tobacco and Alcohol Studies (UKCTAS), University of Nottingham

The MRC is a member of the UKCRC, which brings together the NHS, research funders, industry, regulatory bodies, Royal Colleges, patient groups and academia in a UK-wide environment that facilitates and promotes high-quality clinical research for the benefit of patients. For more information visit: www.ukcrc.org

The UKCRC centres funding partners are the MRC, the British Heart Foundation, Cancer Research UK, NIHR, Economic and Social Research Council, the Public Health Agency, Health and Care Research Wales, Welsh Government, Chief Scientist Office and Wellcome.

© 2024 University of Cambridge

• University A-Z
• Contact the University
• Accessibility
• Freedom of information
• Terms and conditions
• Undergraduate
• Spotlight on...
• About research at Cambridge

• Health Research Classification System
• UK Health Research Analysis

Public Health Research

In 2006, the major funders of public health research in the UK came together under the auspices of the UKCRC to develop a coordinated approach to improving the UK public health research environment. The findings of the UKCRC Public Health Research Strategic Planning Group (SPG) are documented in a report, Strengthening Public Health Research in the UK.

The outcome of the SPG was a commitment of over £20m by a consortium of eight funding partners to create UKCRC Public Health Research Centres of Excellence in 2008.

Since 2008, partners in the UKCRC have invested £37 million in a network of six Public Health Centres of Excellence to increase infrastructure, build academic capacity in public health research in the UK and provide a platform to engage with policy and practice.

The final report shows how 10-years of collaborative work by these centres – based in Edinburgh, Belfast, Newcastle, Nottingham, Cambridge and Cardiff – has exceeded expectations of what was though possible back in 2008.

The UKCRC Centres have expanded the pool of early-career researchers and nutured their talent while creating new opportunities to work across academia, policy and practice. Researchers have gone on to expand their networks and advance their careers, securing fellowships and lectureships, winnning awards and promotion. The UKCRC centres have been a strong magnet for leveraging significant additional funding to increase the volume and quality of public health health research.

The centres have helped change the way we think about how to align research with the needs of policymakers and practitioners to improve health at a local level.

At the national level, the impact has been wide-reaching, with evidence from centre research programmes influencing the government sugar tax, encouraging healthy transport policies, providing guidance on physical activity, promoting health in schols and playing a leading role in government policy on tobacco smoking and vaping.

Centre collaborations and acdemic-policy partnerships have changed the public health landscape, paving the way for ambitious new prevention intitiatives, like the UK Preventation Research Partnership.

The funding Partners contributing to this joint initiative are:

• British Heart Foundation
• Cancer Research UK
• National Institute of Health Research
• Economic and Social Research Council
• Medical Research Council
• Health and Social Care Research and Development Office, Northern Ireland
• National Institute for Social Care and Health Research (Welsh Assembly Government)
• Wellcome Trust

The six UKCRC Public Health Research Centres of Excellence are:

• Centre for Diet and Activity Research (CEDAR)
• Centre of Excellence for Public Health Northern Ireland
• Centre for Development and Evaluation of Complex Interventions for Public Health (DECIPHer)
• Centre for Translational Research in Public Health (Fuse)
• UK Centre for Tobacco Control and Alcohol Studies (UKCTAS)
• The Scottish Collaboration for Public Health Research and Policy

Useful Links

• UKCRC Public Health Research Centres of Excellence Final Report 2018
• Strengthening Public Health Research in the UK 
• Executive Summary: Strengthening Public Health Research in the UK

Together we are beating cancer

About cancer

Cancer types

• Breast cancer
• Bowel cancer
• Lung cancer
• Prostate cancer

Cancers in general

• Clinical trials

Causes of cancer

Coping with cancer

• Managing symptoms and side effects
• Mental health and cancer
• Money and travel
• Death and dying
• Cancer Chat forum

Health Professionals

• Cancer Statistics
• Cancer Screening
• Learning and Support
• NICE suspected cancer referral guidelines

Get involved

• Make a donation

By cancer type

• Leave a legacy gift
• Donate in Memory

Find an event

• Race for Life
• Charity runs
• Charity walks
• Search events
• Relay For Life
• Volunteer in our shops
• Help at an event
• Help us raise money
• Campaign for us

Do your own fundraising

• Fundraising ideas
• Get a fundraising pack
• Return fundraising money
• Fundraise by cancer type
• Set up a Cancer Research UK Giving Page
• Find a shop or superstore
• Become a partner
• Cancer Research UK for Children & Young People
• Our We Are campaign

Our research

• Brain tumours
• Skin cancer
• All cancer types

By cancer topic

• New treatments
• Cancer biology
• Cancer drugs
• All cancer subjects
• All locations

By Researcher

• Professor Duncan Baird
• Professor Fran Balkwill
• Professor Andrew Biankin
• See all researchers
• Our achievements timeline
• Our research strategy
• Involving animals in research

Funding for researchers

Research opportunities

• For discovery researchers
• For clinical researchers
• For population researchers
• In drug discovery & development
• In early detection & diagnosis
• For students & postdocs

Our funding schemes

• Career Development Fellowship
• Discovery Programme Awards
• Clinical Trial Award
• Biology to Prevention Award
• View all schemes and deadlines

Applying for funding

• Start your application online
• How to make a successful application
• Funding committees
• Successful applicant case studies

How we deliver research

• Our research infrastructure
• Events and conferences

Our research partnerships

• Facts & figures about our funding
• Develop your research career
• Recently funded awards
• Manage your research grant
• Notify us of new publications

Find a shop

• Volunteer in a shop
• Donate goods to a shop
• Our superstores

Shop online

• Wedding favours
• Cancer Care
• Flower Shop

Our eBay store

• Shoes and boots
• Bags and purses
• We beat cancer
• We fundraise
• We develop policy
• Our global role

Our organisation

• Our strategy
• Our Trustees
• CEO and Executive Board
• How we spend your money
• Early careers

Cancer news

• Cancer News
• For Researchers
• For Supporters
• Press office
• Publications
• Update your contact preferences

ABOUT CANCER

GET INVOLVED

NEWS & RESOURCES

FUNDING & RESEARCH

You are here

UKCRC Public Health Research Centres of Excellence

The UK Clinical Research Collaboration Public Health Centres of Excellence are a network of five centres across the UK which were established to boost capacity and infrastructure in public health research.

The key objectives of the partnership are to support the growth and sustainability of the public health research community, including by:

• Enabling multidisciplinary and collaborative working
• Promoting training
• Engaging with policy and practice across the UK

The five UKCRC Public Health Research Centres of Excellence are:

Centre for Diet and Activity Research  (CEDAR)

Professor Nick Wareham, MRC Epidemiology Unit Cambridge

Centre of Excellence for Public Health Northern Ireland

Professor Frank Kee, Queens University Belfast

Centre for Development and Evaluation of Complex Interventions for Public Health  (DECIPHer)

Professor Simon Murphy (Cardiff University), Professor Rona Campbell (University of Bristol), and Professor Ronan Lyons (Swansea University)

Centre for Translational Research in Public Health  (Fuse)

Professor Ashley Adamson, Newcastle University

UK Centre for Tobacco Control and Alcohol Studies  (UKCTAS)

Professor John Britton, University of Nottingham

Why we formed this partnership

In 2005, the major funders of public health research in the UK came together to form the UKCRC to address weaknesses in public health research. The group's report –  Strengthening Public Health Research in the UK  – led to the commitment of £21 million to create the five UKCRC Public Health Centres of Excellence.

These Centres are designed to build research capacity, increase infrastructure and promote multi-disciplinary working by bringing together leading research experts together with practitioners, policy makers and wider stakeholders to tackle complex public health issues.

How we operate

Together, the partners committed £21 million to the first round of funding, and £16 million to the second round. We assembled an independent, international Scientific Advisory Panel to oversee the initial competition for the Centres. The Medical Research Council manages the initiative on behalf of the funding consortium, which also includes:

• British Heart Foundation
• Department of Health
• Economic and Social Research Council
• Medical Research Council
• National Institute for Social Care and Health Research  (Welsh Assembly Government)
• Health and Social Care Research and Development  (Public Health Agency, Northern Ireland)
• Wellcome Trust

Our progress

In January 2013 an international scientific panel assessed the progress and impact made by the individual UKCRC Centres and reported that the initiative had been very successful in achieving its initial goals and was at the international forefront of integrating public health research, policy and practice. All five Centres are supported for a second five year term at a cost of £16m.

Find out more

• UK Clinical Research Collaboration

Other opportunities for prevention and population researchers

We support a broad portfolio of prevention and population research aimed at understanding cancer aetiology, risk and incidence, and translating this into future preventive interventions.

We fund investigator-led projects, partnership initiatives, research facilities and resources, and we have a range of opportunities to help you develop your research career.

We partner with like-minded organisations from across the academic, not-for-profit, government and private sectors to deliver mutually beneficial collaborations, from large-scale co-funding of projects and infrastructure to joint workshops and conferences.

NIHR grants £42m to 14 new HealthTech Research Centres across England

The National Institute for Health and Care Research has granted £42 million to the development of 14 new centres in England to drive health tech research, with the aim of working with businesses to support development of medical devices, diagnostics and technologies for use in hospitals, general practice, the community, and social care.

Each of the 14 NIHR HealthTech Research Centres has been awarded just under £3 million toward driving innovation in their specialty and is hosted by an NHS organisation in England, with participating trusts including Cambridge University Hospitals; Guy’s and St Thomas’; Imperial College Healthcare; Leeds Teaching Hospitals; Manchester University NFT; Nottinghamshire Healthcare; Nottingham University Hospitals; Oxford Health NFT; Royal Devon University Healthcare; Sheffield Children’s; Sheffield Teaching Hospitals; South London and Maudsley; Newcastle Upon Tyne NFT; and University Hospitals Birmingham.

Research focuses include brain and spine injury; cardiovascular and respiratory disease; surgical technologies and rehabilitation; and children and young people’s health. The centres will also develop and test products designed to support rehabilitation and independence for those with social care needs.

The scheme replaces the NIHR Medtech and In Vitro Diagnostic Co-operative scheme, which will end in March 2024 before the NIHR Health Tech Research Centres officially launch in April.

Professor Lucy Chappell, chief scientific adviser at the DHSC and CEO of the NIHR, said: “Research into health technology is recognised as being of vital importance for patients, carers and users, our workforce, and the wider health and care system. The establishment of the NIHR Healthtech Research Centres shows our firm commitment to driving innovation in healthtech research from conception through to adoption.

“Our existing research centres in MedTech have delivered new technologies that have helped prevent, diagnose and treat ill health for many individuals, as well as ensuring increased efficiencies in the health and care system. The increased funding for the HealthTech Research Centres will build capacity and  expertise in health technologies, bring new innovations to market and enable people to live healthier, better-quality lives.”

Elsewhere on innovation, NHS England, the NHS Race and Health Observatory and the NHS Innovation Accelerator announced a targeted call for innovations addressing Core20PLUS5 health inequalities over the summer.

Leeds Teaching Hospitals also announced its Innovation Pop-Up in August , looking to engage the market across seven thematic areas – clinical communications, virtual care, operations, SMART buildings, inpatient central monitoring, patient flow and network infrastructure.

• Lincolnshire Partnership launches Virtual Autism Hub with up…
• 92 percent of GP practices in England have cloud-based…
• NHS England plans to roll out AI to help reduce…
• HTN Now: NW London's digital access e-hub for consultations…
• Digital Health and Care Wales 2024-2027 primary care…
• HTN Now: automation in primary care processes with…

HTN Now: optimising referral management with NEC Rego

Join htn for webinars in april: engaging your board and workforce with buy-in, the future of patient portals, and more, panel discussion: what will the cio role look like in 5-10 years, interview: peter kelly, cynerio’s global head of customer success, on the need to think about cyber security differently, featured interview: stefan chetty of restore records management on the benefits of digitisation and wider management of records, royal papworth hospital nhs foundation trust moves to ccube cloud, “user experience and operational improvements” ccube on key edms objectives, interview: wendy blumenow on the benefits of the isla remote monitoring platform at alder hey children’s hospital trust.

National Institute for Health Research, UK

Supporting you translate your innovation into the clinic and on into the NHS

National Institute for Health Research

No matter what stage you are at in the development of your innovation, the National Institute for Health Research is here to support you.

The NIHR's Offer to Industry

The UK’s Department of Health and Social Care invests over £1.2 billion annually through the National Institute for Health Research (NIHR) to fund translational, clinical and applied health research spanning the whole innovation pathway.

Through its people, programmes, centres of excellence and systems, traversing the UK’s health system and leading universities, the NIHR is the most integrated health research system in the world, designed to transform scientific breakthroughs into life-saving treatments and technologies.

As a leading destination for clinical research, the NIHR can support life science companies to generate the required clinical and economic evidence to progress the development of their new therapeutics, medtech, diagnostics and digital products towards market.

We can work with you at any stage of your clinical development pipeline by supporting you:

• Gain access to expertise: introducing you to leading academic and clinical researchers across the UK's Health System and universities; with expertise across a very broad range of disease and technology areas.
• Set up collaborations with UK researchers around experimental medicine / translational research: either evaluating new therapies or technologies in our health system or to gain deeper insights into disease mechanisms.
• Set up and manage both commercial contract and collaborative clinical research across our health system: we offer early feasibility, site and investigator identification, set up and trial performance management.
• Gain access to other research provisions: including data (research and health), access to patients, access to clinical samples or access to facilities/research techniques.
• Access a variety of funding programmes: to help finance your research

We can also support companies to gain access to the wider UK research and health system; including governmental departments, regulators and regional healthtech clusters. 

Useful Information

The NIHR MedTech Offer

Minerva House 5 Montague Close London SE19BB United Kingdom

A specialist healthcare policy research centre

Future Health is a new, future focused Research Centre with a mission to advance public policy thinking that improves the health and wealth of people, communities and nations.

Founded by Richard Sloggett, former Special Adviser to the UK Secretary of State for Health and Social Care, the Centre is researching the health and economic opportunities in building more resilient and preventative healthcare systems enabled by new technologies.

Future Health undertakes cutting edge public policy research that generates new insights and solutions, helping to shape the global healthcare policy debate.

How we work

Future Health seeks to actively collaborate with all those who share our mission of creating healthier, wealthier people, communities and nations. This includes Governments, healthcare system leaders, clinicians and healthcare staff, innovators, suppliers, the voluntary and charity sector, patients and the public.

Future Health is led by Richard Sloggett, former Special Adviser to the Health and Social Care Secretary. Richard leads a small team of associates with expertise in research and healthcare policy.

• About Future Health
• Core Research Programmes
• Global health programme
• News and Opinions

Welcome to the Centre for Ethnic Health Research

The Centre for Ethnic Health Research (CEHR) works to address inequalities, associated with ethnicity, in health care access and health outcomes. We do this by supporting individuals and organisations to involve and understand the needs of ethnic minority and underserved communities when planning and undertaking research and healthcare delivery.

The CEHR is hosted by University of Leicester within NIHR Applied Research Collaboration, East Midlands (ARC EM) which is the lead ARC for Equality, Diversity and Inclusion (EDI) of under-represented groups in research. Located in one of the most ethnically diverse cities in the UK (Leicester), the CEHR is uniquely placed to conduct research on issues affecting the health and health outcomes of these populations, and provides a national network through established links with the Academic Health Sciences Network (AHSN); Clinical Research Networks (CRNs); Integrated Care Systems (ICS’s); National NIHR infrastructures, NHS and Academic institutions, charitable organisations and industry partners.

The CEHR provides opportunities to be at the heart of practical solutions, through focussed work with communities to reduce health inequalities locally and nationally by working with patients, the public, community and voluntary sectors, researchers, and health & social care organisations. We have a number of community engagement officers and research staff who engage with underserved communities and inspire community-led research. We design and deliver resources and alternative methodologies that are informed and led by communities. These methods and our involvement allow us to promote culturally-sensitive resources and raise awareness of community engagement and collaboration across research and healthcare delivery.

We are an organisation that is committed to actively inspiring and developing dynamic and collaborative partnerships between patients, public, community and voluntary sectors, researchers, health and social care organisations and others, to help address ethnic health disparities.

Our Objectives

• Develop and implement capacity building programmes aimed at supporting and enhancing researchers’ skills, knowledge and confidence to produce high-quality research involving the active participation of ethnic minorities and seldom heard communities in all aspects of the research.
• To develop and provide centralised and co-ordinated toolkits and resources for organisations and individuals to share and disseminate good practice in conducting research with ethnic minorities and seldom heard communities.
• Actively influence a culture of practice in which ethnic minority public involvement informs and supports research, service planning, commissioning and delivery of health and adult social care services and healthcare; and where achievements are shared, valued and celebrated.
• Undertake community engagement strategies that foster the trust and support of ethnic minorities and seldom heard of communities to participate in joint working activities related to research and implementation in the field of health and social care, and to resource their capacity to act on this commitment.

The Centre for Ethnic Health Research provides opportunities to be at the heart of practical solutions, through focussed work with communities. It has established links with the Academic Health Sciences Network (AHSN); local Clinical Research Networks (CRNs); Local Clinical Commissioning Groups (CCGs); CLAHRC partner institutions including the University of Nottingham’s Institute for Mental Health; the University of Birmingham and University of Warwick: other institutions within the Midlands Health Innovation Network; and charitable organisations including the South Asian Health Foundation.

Cultural Competence is woven throughout all the work of the Centre for Ethnic Health Research and this methodology will explicitly support the outputs in style, culture, language and approach.

The unique Centre for Ethnic Health Research, situated within the LDC for optimal engagement, offers training and existing infrastructure for public engagement and involvement to help improve the quality, quantity and impact of research output in the area of ethnic and migrant health. It is our understanding of this element through our far-reaching engagement, plus the experience of clinicians that places us in a unique position to both engage and develop appropriately.

Our experience has led to the cultural adaptation of a range of health education and awareness materials.

• Community Involvement

View Our Latest Videos

Partners & Collaborators

Latest News

• Physical activity programme improves lifestyle of South Asian communities in Leicester
• Centre joins new NIHR Research Support Service
• AI ‘must not worsen’ health inequalities for ethnic minority populations
• Virtual dissemination event – Thursday 25 November at 1pm

Centre for Ethnic Health Research

Leicester General Hospital Gwendolen Road Leicester LE5 4PW

Directions to the Centre for Ethnic Health Research

• Annual Reports
• News & Events
• Collaboration
• Terms of Use

Sign Up for News & Updates

You are using an outdated browser. Please upgrade your browser to improve your experience and security.

Centre For Health Research and Education

An independent healthcare company bridging the policy and practice gap in public health for global cancer prevention.

We are an independent healthcare solutions company with global cancer prevention ambitions. We work with organisations across the world to design and implement practical and scalable health interventions. We use innovative approaches for a sustainable, positive impact on peoples’ lives.

At CHRE, we work with organisations and funding bodies from across the world on global cancer prevention projects. Due to the potential scale and global impact of our work, we are currently focusing on reducing the harms from tobacco and separately, childhood obesity prevention.

Latest from CHRE

International women’s day 2022 #breakthebias.

On International Women’s Day 2022, CHRE’s India team launched a campaign for women tobacco users - smokers as well as oral tobacco users- to demand attention and support for tobacco cessation from their healthcare professionals.

Get in touch

Centre for Health Research and Education, 2 Venture Road, University of Southampton Science Park, Chilworth, Hampshire, SO16 7NP

2024 CHRE All Rights Reserved

• Terms & Conditions
• Privacy Policy

Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

NIHR HealthTech Research Centres - Stage 1 Application Guidance

Published: 18 August 2022

Version: v1.0 August 2022

Introduction

The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. NIHR delivers against this mission through six core workstreams set out in Best Research for Best Health - the next chapter .

The NIHR is launching a new, two-stage, open competition to designate and fund NIHR HealthTech Research Centres (HRCs) in England. This scheme replaces the current NIHR Medtech and In Vitro Diagnostic Cooperative (MIC) scheme.

A total of up to £45 million over five years is available for this round of NIHR HRC funding from 1 April 2024. Eligible NHS organisations may submit one application.

HealthTech refers to any technology, device or digital solution designed to improve health and care. It includes medical devices, diagnostics (including in vitro diagnostics) and digital health technologies.

Please see our  frequently asked questions document for a full list of published questions. In addition,  we will provide answers to any additional queries submitted through our online form which will be open until 19 October 2022.

NOTE: Applications for Stage 1 are now closed.

The aims of the NIHR HealthTech Research Centres are to:

• catalyse innovation in the development of new HealthTech for areas of unmet need, areas of high disease burden, and/or improve efficiencies in the health and care system.
• provide expertise to evaluate innovations and generate appropriate evidence to support uptake into the health and care system. End-user engagement should be central to design and testing to ensure products are fit for the intended purpose or setting (patients, the public or the health and care system).
• work collaboratively with the wider adoption landscape to improve efficiencies in translating research into benefits for patients and the public, the health and care system and for wider economic gain.
• increase the system's capacity to work at the interface between industry, academia and the health and care system through training and support for those managing the commercialisation process. This will include increasing the understanding of market access requirements to improve the uptake of innovations.
• build capacity and expertise in methodological approaches (e.g. health economics, human factors, care pathway assessments etc) to generate robust evidence.
• contribute to regional and national economic growth through supporting UK-based SMEs and encouraging inward investment and trade by supporting companies to bring innovations to market in the UK and other regulated jurisdictions.

HRCs will be centres of excellence that support the development of HealthTech and the generation of appropriate evidence to support necessary approvals and enable effective implementation of innovations to improve care and the health and care system. 

Each NIHR HRC will be led by a Director with proven experience of leadership in developing and implementing novel technologies in the health and care system e.g. NHS, public health, and/or a social care setting. NIHR HRC funding will enable a range of collaborating partners and stakeholders to be brought together to generate a programme of work, leading to the generation of high-quality follow-on research projects. This will include engaging and working alongside multidisciplinary teams of health and care professionals, researchers, patients and the public, industry, regulators, NHS commissioners and Integrated Care Systems to identify needs and issues from a front-line service and patient/public (including carers and service users) perspective.

NIHR HRCs will use their extensive knowledge of the innovation pipeline to primarily support industry partners navigate the health and care landscape, including the regulatory requirements for market access to increase the chance of adoption. When supporting academically led innovations, there will be an expectation of future commercialisation. Innovations supported by the NIHR HRCs should seek to address areas where there is demonstrable unmet need from the health and care system. NIHR HRCs should support growth of local/regional innovation clusters while ensuring their expertise remains accessible to UK and global companies, working as part of the NIHR to remove geographical barriers to research and generating evidence that has the potential to have a national impact.

Each NIHR HRC will be expected to have access to a range of relevant expertise to support generation of evidence on safety, validity, utility, cost effectiveness, care pathway benefits and ‘real-life’ applicability (real-world evidence) of HealthTech innovations. 

While the focus of the remit of activity within an NIHR HRC funded by the award will be the development of collaborations, the NIHR HRC scheme will also fund relevant pilot/proof of concept studies. These pilot/proof of concept studies should aim to support further larger scale research projects, including aspects such as full development, health economics and care pathway assessment. NIHR HRCs are expected to leverage additional research funding, including from other public, charity and industry research funding sources to undertake full scale studies.

To support the development and adoption of products, NIHR HRCs will be expected to work closely with the relevant parts of the health and care system including the Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Health and Care Excellence (NICE), NHS England, Academic Health Science Networks (AHSNs) and the NHS Innovation Service.

Please note, NIHR HRCs will be expected to be responsive to support national health and care priorities. Priorities within the health and care system change, and NIHR HRCs will need to be responsive to emerging needs and situations can arise (nationally and globally) which require access to research, research expertise and resource at short notice. NIHR HRCs will be expected to prioritise resource towards addressing national health and care priorities at the request of the Department for Health and Social Care (DHSC).  

Skills and Workforce Development

NIHR HRCs will have a remit to support the development of a highly skilled research workforce to support the development of HealthTech and meet growing demands in this area. This should include skills development in areas such as methodology, health economics, human factors, care pathway assessments and commercialisation. NHS organisations will be expected to demonstrate how they will support skills and workforce development, through the provision of both theoretical and practical training. Consideration should be given to providing support across the career development pathway for staff at all levels from early training into continuous professional development to build capacity and expertise within the NIHR HRC.

Eligibility Criteria

All NHS organisations in England that can demonstrate a substantial portfolio of HealthTech research are eligible and may submit one application. NIHR HRC designation will be awarded to a single NHS organisation. 

The NHS organisation may identify additional NHS organisations and/or universities who would form part of the designated NIHR HRC and would work with the contracted NHS organisation to deliver its programme of work. These organisations should have specified roles in the application. NIHR HRCs are encouraged to work with NHS organisations and/or universities that bring additional strength and depth to the HRCs workplan and build research capacity and expertise across the country.

In addition, the NIHR HRCs may collaborate with other non-NHS organisations non-NHS organisations (care providers or organisations from the independent sector providing health and care services) or Universities and can pass funding to them via an appropriate mechanism, such as a subcontract.

Funding Available

A total of up to £45 million is available for the NIHR HRC scheme over a five-year period (starting 1 April 2024). The number of Centres and the amount of funding allocated to each NIHR HRC has not been predetermined however funding is expected to be n o more than £3 million per centre for the five-year period. Funding will be informed by the scale, nature and quality of the research activity to be conducted by that Centre.

Competition Process and Timetable

Stage 1: selection criteria.

At Stage 1 an Independent Selection Committee will review the applications and make recommendations to DHSC on which applicants should be invited submit a Stage 2 application. The information provided in the Stage 1 application will be assessed against the following selection criteria: 

• the strength of the strategic plan ; including a commitment to collaborative working to support industry;
• the depth and breadth of high-quality HealthTech research;
• existing capacity and capability to support the development and commercialisation of HealthTech innovations.

Stage 2: Applicants invited to Stage 2 will be provided with further guidance. The selection criteria for Stage 2 are provided for information in Annex 3.

Annex 1: outline of the stage 1 application form, applications must be submitted electronically via the research management system (rms). the following information will be requested: 1. details of the proposed nihr hrc.

Please use the following format NIHR- Name of the NHS Organisation- HRC

2. Director(s) of the proposed NIHR HRC

Please provide the name(s) of the proposed Director(s).

3. Please provide details of the host NHS organisation 

Please select the name of the host NHS organisation using the drop-down menu.

4. Please provide details of any other partners

Please list any additional NHS organisations that will be formal partners in the NIHR HRC. Formal agreement from these partners will be sought at Stage 2.

Please note: NIHR HRC designation will be awarded to a single NHS organisation. The NHS organisation may identify additional NHS organisations and/or universities who would form part of the designated NIHR HRC and would work with the contracted NHS organisation to deliver its programme of work. These organisations should have specified roles and should be listed in this section of the application.

In addition, the NIHR HRCs may collaborate with non-NHS organisations (care providers or organisations from the independent sector providing health and care services) or Universities and can pass funding to them via an appropriate mechanism, such as a subcontract. Please refer to these organisations in the application but do not list them as formal partners in this section.

5. Overall funding requested

Please provide an indicative total cost for the proposed NIHR HRC, this value should be within 5% of the final costs that will be submitted in a Stage 2 application. A full breakdown of costs will be required at Stage 2.

6. Proposed Director(s) leadership and expertise (500 words)

Please summarise the proposed Director(s) leadership and expertise in developing and implementing novel technologies in a health and care system. This should include:

• The organisational leadership experience of the Director(s), including examples of leadership at a local, regional and/or national/international level;
• Evidence of their experience in progressing HealthTech products through the innovation pathways and supporting commercial partners and/or the commercialisation of innovations;
• A statement highlighting the Director’s commitment to, and experience of, improving research culture and equality, diversity and inclusivity in the research workforce; and
• Up to 3 (including URL) that outline the Directors expertise in developing or implementing HealthTech research.

Note: Doesn’t necessarily have to be a peer reviewed publication e.g. if the Director has been a major contributor to NICE guidelines that would be accepted.

7. Expertise in translating HealthTech research

7.1 Please provide a brief description of the cross-cutting expertise which will underpin the activities of the NIHR HRC. (500 words)

Please describe the approach and strategy of the proposed NIHR HRC for working with industry, including examples of key strategic industry partnerships already in place that are directly relevant to the proposed Themes (500 words)

7.2 Please provide up to three case studies which highlight previous successes in working with industry to move HealthTech products along the innovation pipeline towards adoption. The case study should demonstrate how the NHS organisation and industry work together as partners, fully utilising both sets of unique expertise, and the benefit industry receives in working with the NHS. The information presented should be understandable to both lay and expert members of the committee. Text should be written in plain English without use of jargon and any technical terms should be explained. (400 words per case study)

8. Outline Strategic Plan

8.1 In plain English, briefly summarise the vision, scientific rationale/context and goals of the proposed NIHR HRC. (500 words)

8.2 Please provide a description of the proposed NIHR HRC. Please include the areas to be addressed as a set of ‘Themes’ and how the themes will dovetail into a coherent Centre. The plan should set out how the Centre will meet the published aims of the scheme. The NHS organisation’s approach to improvements in research culture and plans to support equality, diversity and inclusion across the proposed activities should be clearly explained. (1500 words)

9. Table of NIHR HRC Themes

Please list the Themes that will be included in the proposal.

For each Theme please provide:

• the name of the Theme Lead(s) and co-Theme lead (where applicable); and
• a short title.

Please note: The organisation and ORCID number for the Directors, lead and co-leads for each theme will be taken from their portal account ('Manage my Details' section) which should be updated prior to submission.

PPIE and training should not be included as individual themes but should be embedded within the research themes.

10. Theme Summary (400 words per theme)

Please provide a short abstract for each Theme highlighting the areas of need to be addressed and the potential outcomes of benefit to patients, the public, and the health and care system. Outline the expertise and track record of the proposed team in this area.

Annex 2:  Stage 2 - Financial Information

1. the purpose of nihr healthtech research centre (hrc) funding.

The purpose of the funding is to meet the NHS research infrastructure costs incurred by the NIHR HRC in carrying out an approved programme of HealthTech research.

Our expectation is that NIHR HRC funding will fund a team of staff who will enable a range of collaborating partners and stakeholders to be brought together to generate a programme of work, leading to the generation of high-quality follow-on research projects supported by other research funders (e.g. research councils, charities, industry or other NIHR funding streams e.g. i4i, HTA and EME) and/or in collaboration with industry.

Funding awards will be made to the designated NHS organisation, but it is permissible for funds to flow to other organisations that are formally part of the NIHR HRC, via a suitable mechanism such as a subcontract.

2. The financial plan

The financial plan should provide a breakdown of the NHS Research Infrastructure direct costs, reasonable NHS indirect costs and eligible NHS Support Costs and for which funding is being requested to carry out the proposed work plan.

It is important to undertake a thorough, realistic and accurate costing. You must provide a clear and full justification for all major resources. You must also ensure that you include all costs, including those required to secure good research management and governance. In all cases, the value for money of the proposal will be an important selection criterion.

3. Supporting Information

Prior to completing the finance section of the application it is important applicants have a good understanding of the Attributing costs of health and social care Research and Development (AcoRD) guidance .

The AcoRD guidance clarifies the distinction between research costs, NHS support costs and NHS treatment costs associated with non-commercial research studies/programmes:

We strongly recommend that applicants familiarise themselves with these definitions, and consult AcoRD Annex A and AcoRD Annex B as well as the NIHR webpage on Excess Treatment costs

Please note the following:

• Applicants need to separate eligible direct, indirect research costs as well as NHS support costs. The finance form is formatted to allow applicants to separate these costs. Guidance on how to complete the finance form is provided within the finance section of the application.
• Further itemisation of costs and explanation of calculation methods may be requested to support the application if required.
• Applications should be costed at current (2022/23) prices.
• We expect standard NHS accounting policy and guidance to be followed (as set out in the NHS Finance Manual) in determining the appropriate costs to be charged to this Research Infrastructure Award.
• Where necessary applications are expected to have appropriate NHS, university, commercial and other partner input into the finance section.
• The NIHR will not support any costs incurred, prior to, or following the completion date of the infrastructure award.
• Years should be calculated starting from the start date of the proposed award i.e. 1 April 2024. Once an award has been made DHSC will require host organisations to provide regular financial statements regarding the use of funds provided under the NIHR funding scheme. DHSC reserves the right to send independent auditors to the NHS organisation to confirm the actual use of funds.
• Payments will only be made to the contracted organisation who will take responsibility for distributing any funds to any Partner(s).
• Appropriate research project agreement and/or sub-contracts must be put in place for any element of the work programme that is to be paid to another organisation.

4. Information for Different Types of Organisations

4.1 nhs organisations.

Up to 100% of direct and indirect research costs as well as NHS support costs incurred by NHS organisations will be funded.

4.2 Universities

NIHR HRC funding will fund up to 100% of direct research costs for universities. NIHR HRC funding does not pay indirect costs for universities.

4.3 Commercial organisations

Up to 100% of direct and indirect research costs will be funded for commercial organisations or consultancies. Commercial organisation indirect costs need to demonstrate value for money. The NIHR reserves the right to set limits on indirect costs charged.

4.4 Other partner organisations

Up to 100% of direct and indirect research costs will be funded for partner organisations (local authorities, charities, non-governmental organisations, etc.). Other partner organisation indirect costs need to demonstrate value for money. The NIHR reserves the right to set limits on indirect costs charged.

5. Eligible Costs

5.1 direct costs, 5.1.1. overview of direct costs.

Direct costs are eligible research infrastructure costs that will be incurred by the NHS organisation in carrying out the proposed work programme for the NIHR HRC. These costs should be recorded and supported by an appropriate audit trail.

Eligible direct costs are listed below.

5.1.2 Annual costs of staff posts and salaries

The NIHR HRC award will reimburse the time of staff engaged in the NIHR HRC’s work programme. Salaries may be sought for core NIHR HRC research, research support or other staff, required to work full or part-time on the NIHR HRC’s research programme.

Newly established posts should be created with an NHS organisation as the employer. It is permissible for staff to be employed by university partners named on the application where justified, but NIHR will not fund the associated indirect costs for these staff.

All staff members working on the NIHR HRC award must be costed at FY22/23 prices, based on current salary scales and increments. Where staff will be recruited for the proposed NIHR HRC, please provide the estimated annual salary using current rates of pay and build in any known annual increments. Nationally or locally agreed pay increases should be excluded.

Please note that annual increments should be based on the Agenda for Change pay arrangements as applicable on 1 April 2021. Trusts will not be able to claim the costs of pay awards retrospectively.

5.1.3 Travel, subsistence and conference fees

Travel costs

Enter the total cost of travel for all anticipated journeys. If travel is by car, apply your institution’s mileage rates (this should not exceed HMRC approved mileage allowance payments, which is 45p per mile for the first 10,000 miles and 25p thereafter). Travel by the most economic means possible is encouraged; NIHR funding schemes do not usually fund first class travel. Only a reasonable level of international travel will be considered.

Subsistence

Subsistence covers accommodation, where necessary, and any meals associated with the travel but excluding alcoholic beverages.

Conference fees

UK conference attendance is supported where justified. Costs associated with international conference attendance should be individually stated and fully justified.

5.1.4 Equipment

There is no DHSC capital funding available through the NIHR HRC funding scheme. Purchase or lease costs for essential items of equipment as well as maintenance and related costs not included as part of estates can be included. Only purchase costs for pieces of equipment up to £5,000, excluding VAT, will be considered. Pieces of equipment costing more than £5,000 to purchase will need to be leased.

Items of equipment valued at £250 or more must be itemised separately; however, grouping the same type of equipment is permitted. Costs of computers are normally restricted to a maximum of £1000 each excluding VAT. A statement of justification must be included in the relevant ‘Justification of Costs’ section for any purchase above this limit.

Equipment must exclude VAT, but if the organisation incurring the cost is not VAT registered and cannot claim back VAT on cost items, then it would have to enter the gross value of a cost item (including VAT) on the financial plan. You will need to seek advice from the organisation that the piece of equipment is purchased from regarding its VAT status.

The cost of equipment maintenance contracts should be included in this section.

5.1.5 Consumables

This section includes non-reusable items specific to the NIHR HRC’s work plan. Please itemise and describe the requirements fully. These items should be research specific, not just general office costs which should be covered by indirect costs.

5.1.6 Patient and public involvement and engagement (PPIE)

Offering members of the public payment for their time, skill and expertise is considered good practice in structuring and operating the proposed NIHR HRCs. Please itemise and describe fully all costs to support the delivery of the NIHR HRCs patient and public involvement and engagement strategy. This will include:

• Costs to support novel involvement and engagement mechanisms such as community engagement, digital engagement or other models that broaden reach.
• Payments to recognise time, skills and expertise contributed by public members.
• All out of pocket expenses incurred by public members in supporting the NIHR HRCs PPIE activities. Equal opportunities for involvement are facilitated if expenses are covered. Members of the public should not end up financially worse off for providing a public service.

NIHR has produced guidance to help staff supporting reach identify and calculate costs of public involvement in their research facing activities.

Note: Costs of staff posts to support the delivery of the PPIE strategy should be included in the Staff Posts and Salaries and Annual Costs of Staff Posts tabs. Costs for PPIE activities should be included in the research themes. Costs for cross cutting PPIE leadership e.g. the PPIE Lead should be included in the CORE costs.

5.1.7 Open Access Costs

This includes any associated with Open Access Publishing. Please review the NIHR Open Access Policy and the NIHR Open Access publications funding guidance .

For  NIHR Infrastructure awards , including the NIHR HRCs, Open Access costs should be budgeted and earmarked by applicants at application stage. Costs for Open Access must be entered and reported as a separate item on the finance form. Contractors are expected to manage Open Access funding equitably, transparently, and in accordance with the Open Access policy throughout the duration of the award.

5.1.8 Dissemination Costs

Any costs associated with presentation or dissemination (excluding Open Access costs, travel and subsistence costs) can be included here. All events must be run at the lowest possible cost, with minimal catering.

5.1.9 Other direct costs

These are costs that have been not identified elsewhere but are specifically attributable to the research infrastructure. For example, external consultancy costs, software licensing, PhD tuition fees and advertising costs.

Please note that external consultants must not be people who are already employed by any NHS organisations, equivalent non-NHS settings, or organisations from the independent sector providing NHS services and other universities, who will be conducting research activities via an appropriately justified subcontract. If they are, any costs should be entered as direct costs in the ‘Staff Posts and Salaries’ and ‘Annual Costs of Staff Posts’ sections.

5.2 Indirect Costs

NIHR HRC awards will fund legitimate and reasonable, indirect costs for the NHS, commercial and other partner organisations. This will include the proportion of the costs of accommodation in the NHS used for the NIHR HRC's work, and an appropriate proportion of HR, payroll, and finance costs. Please seek advice from your finance department about the appropriate cost for this section. Total indirect costs must be fully justified, outlining the rate charged.

NIHR will not meet indirect costs incurred by universities involved in delivering the work of the NIHR HRC.

All indirect costs need to demonstrate value for money. The NIHR reserves the right to set limits on indirect costs charged.

5.3 NHS Support Costs

NIHR HRC awards will fund the NHS Support Costs that are integral to the proposed NIHR HRC’s work programme, and these costs should be included in the application.

NHS Support Costs are the additional patient care costs associated with the proposed work programme of the NIHR HRC, which would end once the R&D activity in question has stopped, even if the patient care service involved continues to be provided. These might cover items such as staff time to recruit and consent patients, or additional activities which will not form part of the on-going intervention.

For single centre non-commercial research, any NHS support costs should be met through the NIHR HRC award.

It should be noted that there are other NIHR funding schemes used to support the cost of NHS infrastructure for research within the NHS ( e.g . NIHR Clinical Research Network), and that NHS infrastructure and support costs associated with work outside the scope of the NIHR HRC award should not be included within the application.

The NHS Support Costs should be separated into staff costs and other (non-staff) costs (including pharmacy, pathology and imaging).

For the following, the appropriate NHS Support costs, or equivalent for non-NHS settings, should be sought through the NIHR Clinical Research Network (NIHR CRN) for studies which meet the NIHR CRN Portfolio eligibility criteria:

• NIHR HRC-led research studies within third party collaborating NHS, or equivalent non-NHS setting, site ( e. not a formal site of the host NHS organisation, or not formally subcontracted by the host NHS organisation for the purposes of the NIHR HRC);
• Research funded by NIHR’s non-commercial research partners (for example UKRI, medical research charities) conducted within the NIHR HRC’s work programme; and
• Research funded by NIHR research programmes (for example HS&DR, i4i and Health Protection Research Units).

6. Ineligible Costs

The funding is not intended to meet NHS Treatment costs associated with the research programme of the NIHR HRC award.

Funding will not be provided for university laboratories or infrastructure, or to meet the costs of animal research, or costs of audits of practice and service evaluations. Please refer to the UK Policy Framework for Health and Social Care Research for further details.

NIHR HRC awards will not fund indirect costs for universities.

Equipment costing more than £5,000 will not be funded via the NIHR HRC award.

No capital funding is available through this award. Research activities should be undertaken within existing facilities or planned facilities for which there is confirmed funding.

Centres and institutes

We provide substantial funding to a number of large research projects and centres in the UK.

Future manufacturing research hubs

Learn how we support the commercialisation of early-stage research in emerging areas

Academic centres of excellence in cybersecurity research

How we work with academia and industry to make the UK more resilient to cyber attacks

Henry Royce Institute

Read about the institute’s work in advanced materials research and innovation

The Alan Turing Institute

The Turing is the UK's national institute for data science and artificial intelligence

Rosalind Franklin Institute

The Franklin is a national research institute developing new technologies to tackle health research challenges

UK Collaboratorium for Research in Infrastructure and Cities

Learn how we’re supporting work to develop a world-class national infrastructure capability

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .

Cookies on GOV.UK

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.

We also use cookies set by other sites to help us deliver content from their services.

You have accepted additional cookies. You can change your cookie settings at any time.

You have rejected additional cookies. You can change your cookie settings at any time.

• Health and social care
• Public health
• Health conditions

Diagnostic checks rolled out to 160 sites under CDC programme

Community diagnostic centre (CDC) sites have already delivered over 7 million tests, checks and scans to patients across England.

• Latest statistics show sites have already delivered more than 7 million tests, checks and scans across England
• CDC programme is backed by part of £2.3 billion - the largest cash investment in MRI and CT scanning capacity in the history of the NHS
• Services play a vital role in speeding up diagnosis and treatment, helping to further reduce pressure on hospitals

Patients can now benefit from vital tests, checks and scans being delivered at 160 sites across England as part of the CDC programme, Health and Social Care Secretary Victoria Atkins announced today (11 April 2024).

Based in shopping centres and university campuses - as well as NHS hospitals - CDCs play a vital role in identifying and treating illnesses such as cancer and heart disease.

The government pledged to roll out additional diagnostic tests and scans from a network of 160 sites across the country by March 2025 as part of the CDC programme. Almost a year ahead of the original target date, the CDC programme is now delivering activity on 160 sites.

The rollout is helping to reduce pressure on hospitals and allow for a speedier diagnosis, so patients receive potentially life-saving care sooner.

The latest statistics show that patients have already benefited from over 7 million tests, checks and scans delivered through CDC funding across England.

Health and Social Care Secretary Victoria Atkins said:

We know early diagnosis and treatment are vital, and by rolling out additional tests, checks and scans at 160 sites, we’re improving health outcomes for millions of NHS patients across England. We’re delivering record diagnostic tests, record levels of investment and embracing the latest technology across the NHS to deliver care to people when and where they need it. We remain determined to deliver our long-term plans to cut waiting lists, reduce pressures and make the NHS faster, simpler and fairer for patients.

Health Minister Andrew Stephenson said:

Having visited several CDCs up and down the country, I know how important it is for patients’ health and reassurance to get a speedy diagnosis. By rolling out additional services at 160 sites, we’re making it quicker and easier than ever for patients to undergo these important checks.

The CDC programme provides increased diagnostic capacity across services including MRI and CT scanning equipment, X-ray, audiology and endoscopy, as well as respiratory tests and phlebotomy services.

These are used for diagnosis and monitoring of a wide range of conditions, including cancer, heart disease, respiratory diseases, musculoskeletal diseases and neurological conditions.

Professor Sir Mike Richards, author of an independent review of diagnostic services in the NHS, said:

The NHS has made great progress in establishing community diagnostic centres, which were a key recommendation in my 2020 report. Demand for diagnostic tests continues to rise and these new facilities - which amount to the biggest central cash investment in MRI and CT capacity in the history of the NHS - are providing much needed additional capacity.  From my visits around the country, I have seen how much they are appreciated both by patients and NHS staff.

Last month, Chancellor Jeremy Hunt announced further investment in the sector, promising 100 new AI -fitted MRI scanners that will help doctors deliver results more quickly and accurately to 130,000 patients every year.

These will be funded through the landmark £4.2 billion public sector productivity plan, under which the NHS will be given £3.4 billion to double its investment in digital transformation, including IT upgrades and AI investment.

The CDC programme is backed by part of a £2.3 billion funding package, which constitutes the largest cash investment in MRI and CT scanning capacity in the history of the NHS.

Patients can be referred to CDCs via their GP or acute consultant, and healthcare staff use CT scanners, MRI scanners and other new diagnostic equipment to diagnose a range of health conditions.

List of CDC sites

List of active CDC sites, including those delivering activity from a temporary site while the permanent CDC building is completed.

This list includes 160 CDC sites delivering activity. This includes CDC sites where the activity is being delivered on a temporary basis from the CDC location or nearby health settings via use of mobiles or extended additional hours of operation, funded and enabled by the CDC programme, while the final location is completed. Of the 160 CDCs delivering activity, 55 sites are currently delivering activity using temporary facilities.

East of England:

• Bishops Stortford CDC
• Braintree CDC
• Clacton CDC
• James Paget University Hospital CDC
• Lloyds Court CDC
• New QEII Hospital CDC
• North Bedfordshire CDC
• Northgate CDC
• Peterborough CDC
• Southend CDC
• Thurrock CDC
• West Essex CDC  
• Whitehouse Health Centre CDC
• Wisbech CDC
• Barking Community Hospital CDC
• Eltham Community Hospital CDC
• Finchley Memorial Hospital CDC
• Kingston CDC
• Mile End Hospital CDC
• NWL Ealing CDC
• Queen Mary’s Hospital Roehampton CDC
• Queen Mary’s Sidcup CDC
• St Georges Hornchurch CDC
• Wembley CDC
• Willesden CDC
• Wood Green CDC
• Brierley Hill CDC
• Cannock Chase CDC
• Corbett CDC
• Coventry City CDC
• Florence Nightingale Community Hospital CDC
• Grantham CDC
• Hereford City CDC
• Hinckley CDC
• Ilkeston Community Hospital CDC
• Kidderminster Treatment Centre CDC
• Kings Heath CDC
• Leicester CDC
• Lincoln CDC
• Mansfield CDC
• North Solihull CDC
• Northampton CDC
• Nottingham City CDC
• Rugby St Cross CDC
• Sir Robert Peel CDC
• Skegness CDC
• South Birmingham CDC
• South Warwickshire CDC
• Stoke On Trent CDC
• STW CDC - Telford
• Walton Hospital CDC
• Warwickshire North CDC
• Washwood Heath CDC
• Whitworth Hospital CDC

North East and Yorkshire:

• Armley Moor CDC
• Askham Bar CDC
• Barnsley Glassworks CDC
• Beeston CDC
• Bishop Auckland CDC
• Bradford District and Craven CDC
• East Riding Community Hospital CDC
• Friarage CDC
• Halifax CDC
• Hartlepool CDC
• Huddersfield CDC
• Hull and East Riding CDC
• Metrocentre CDC
• Montagu Hospital CDC
• North Cumbria CDC
• North East Lincolnshire CDC
• Rotherham Diagnostics CDC
• Scarborough Gateway CDC
• Selby War Memorial CDC
• Tees Valley CDC (new location)
• Wakefield CDC

North West:

• Burnley CDC
• Clatterbridge Diagnostics CDC
• Congleton War Memorial CDC
• Crossland Day Hospital CDC
• Ellesmeere Port CDC
• Fleetwood CDC
• Heysham CDC
• Liverpool Womens CDC
• Manchester & Trafford CDC
• North Manchester CDC
• Northern Care Alliance Oldham CDC
• Paddington CDC
• Preston Healthport CDC
• Rossendale CDC
• Salford CDC
• Shopping City CDC
• South East Manchester CDC
• Southport CDC
• St Helens CDC
• Victoria Infirmary Northwich CDC
• Warrington and Halton CDC
• Westmorland CDC
• Whitegate Drive CDC

South East:

• Amersham Hospital CDC
• Andover CDC
• Bexhill CDC
• Bognor Regis War Memorial Hospital CDC
• Bracknell CDC
• Brighton CDC
• Buckland Community Hospital CDC
• Caterham Dene CDC
• Crawley Collaborative CDC
• Dartford, Gravesham and Swanley CDC
• Fareham Community Hospital CDC
• Heatherwood CDC
• Lymington New Forest Hospital CDC
• Milford Community Hospital CDC
• Oak Park CDC
• Portsmouth CDC
• Queen Victoria Hospital CDC
• Royal South Hants CDC
• Southlands Hospital CDC
• University of Chichester Bognor CDC
• West Berkshire Community Hospital CDC
• West Kent CDC
• Woking Community Hospital CDC

South West:

• Boscombe AECC CDC
• Bridgewater CDC
• BSW Banes CDC
• Camborne and Redruth CDC
• CIOS Bodmin CDC
• Devon and Torbay CDC
• Devon Exeter Nightingale CDC
• East Somerset CDC
• Gloucestershire Quayside CDC
• North Bristol CDC
• Plymouth CDC
• Poole Beales CDC
• Poole Dorset heath village CDC
• Salisbury CDC
• Somerset West  CDC
• South Petherton CDC
• South Walks CDC
• Taunton Central CDC
• West Cornwall CDC
• West Mendip CDC
• Weymouth CDC

Share this page

The following links open in a new tab

• Share on Facebook (opens in new tab)
• Share on Twitter (opens in new tab)

Is this page useful?

• Yes this page is useful
• No this page is not useful

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.

To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.